Corcept Therapeutics achieved positive results in the ROSELLA trial for ovarian cancer treatment, leading to an 8% increase in share price despite market challenges. With successful clinical trials and financial growth, Corcept stands out in the pharmaceutical industry.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay